Luoxin Pharmaceuticals Group Stock Co., Ltd.

XSEC:002793 Voorraadrapport

Marktkapitalisatie: CN¥4.7b

Luoxin Pharmaceuticals Group Stock Balans Gezondheid

Financiële gezondheid criteriumcontroles 1/6

Luoxin Pharmaceuticals Group Stock has a total shareholder equity of CN¥2.2B and total debt of CN¥1.9B, which brings its debt-to-equity ratio to 86%. Its total assets and total liabilities are CN¥4.9B and CN¥2.7B respectively.

Belangrijke informatie

86.0%

Verhouding schuld/eigen vermogen

CN¥1.85b

Schuld

Rente dekkingsration/a
ContantCN¥684.91m
AandelenCN¥2.15b
Totaal verplichtingenCN¥2.74b
Totaal activaCN¥4.89b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Analyse van de financiële positie

Kortlopende schulden: 002793's short term assets (CN¥2.0B) do not cover its short term liabilities (CN¥2.4B).

Langlopende schulden: 002793's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥328.4M).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 002793's net debt to equity ratio (54.2%) is considered high.

Schuld verminderen: 002793's debt to equity ratio has increased from 29.8% to 86% over the past 5 years.

Schuldendekking: 002793's operating cash flow is negative, therefore debt is not well covered.

Rentedekking: Insufficient data to determine if 002793's interest payments on its debt are well covered by EBIT.


Balans


Ontdek gezonde bedrijven